XML 40 R35.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation (Detail) - Summary Of Changes In SARs Outstanding (Stock appreciation rights (SARs), USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2015
Dec. 31, 2014
Stock appreciation rights (SARs)
   
SARs [Roll Forward]    
Outstanding at December 31, 2014 (in shares) 1,400,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Granted (in shares) 300,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Outstanding at March 31, 2015 (in shares) 1,700,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
[1],[2] 1,400,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Vested and exercisable at March 31, 2015 (in shares) 900,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
[1]  
Per Share Weighted- Average Exercise Price [Roll Forward]    
Outstanding at December 31, 2014 (in Dollars per share) $ 44.44it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Granted (in Dollars per share) $ 77.92it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Outstanding at March 31, 2015 (in Dollars per share) $ 51.05it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
[1],[2] $ 44.44it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Vested and exercisable at March 31, 2015 (in Dollars per share) $ 38.67it_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedandExpectedtoVestExercisableWeightedAverageExercisePrice.
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
[1]  
Per Share Weighted Average Grant Date Fair Value [Roll Forward]    
Outstanding at December 31, 2014 (in Dollars per share) $ 13.26us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Granted (in Dollars per share) $ 17.56us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Outstanding at March 31, 2015 (in Dollars per share) $ 14.13us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
[1],[2] $ 13.26us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Vested and exercisable at March 31, 2015 (in Dollars per share) $ 12.58it_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedExpectedtoVestandExercisableWeightedAverageGrantDateFairValue.
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
[1]  
Weighted Average Remaining Contractual Term [Roll Forward]    
Outstanding at December 31, 2014 4 years 5 months 82 days [1],[2] 4 years 4 months 2 days
Granted 6 years 6 months 131 days  
Outstanding at March 31, 2015 4 years 5 months 82 days [1],[2] 4 years 4 months 2 days
Vested and exercisable at March 31, 2015 2 years 15 months 92 days [1]  
[1] Total SARs outstanding had an intrinsic value of $52.5 million. SARs vested and exercisable had an intrinsic value of $38.1 million.
[2] As of March 31, 2015, 0.8 million of the SARs outstanding were unvested. The Company expects that substantially all of these unvested awards will vest in future periods.